drugset / Trial / NCT04111822

Pilot Study on the Use of Hydrocortisone, Vitamin c and Tiamine in Patient With Sepsis and Septic Shock

NCT04111822

Phase 3 Completed 40 enrolled Cristina Martinez
RandomizedParallel-groupOpen-labelTreatment

Summary

Due to the high incidence, mortality and short and long term complications of sepsis and septic shock, it is necessary to look for strategies to try to minimize this impact.

Timeline

Start
2018-10-31
Primary completion
2020-10-31
Completion
2020-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic
Background Tranexamic Acid Small molecule